Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>Xuefu Zhuyu decoction (XFZYD) is a traditional Chinese herbal prescription. It is effective in treating traumatic brain injury (TBI). However, the underlying molecular mechanisms remain unclear.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>This study aimed to reveal the possible mechanisms of XFZYD in treating acute TBI through proteomic clues.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>Controlled Cortical Impact (CCI) rats were gavaged with XFZYD (9 g/kg/d) or distilled water (equal volume) for three days. The Modified Neurological Severity Score (mNSS), brain water content, HE staining, Nissl staining and immunohistochemistry were performed to assess the effects of XFZYD in treating TBI. Additionally, Tandem mass tag-based (TMT) quantitative proteomics technology was applied to detect proteins of the extracted brain cortex. Bioinformatics analysis including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, Protein-protein interaction (PPI) networks were used to analysis differentially expressed proteins (DEPs). Bioinformatics Analysis Tool for Molecular mechanism of TCM (BATMAN-TCM) was applied to anchore diseases and pathways of XFZYD. Besides, western blotting and immunofluorescence were used to verify related proteins.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>XFZYD improved neurologic function, reduced encephaledema and ameliorated cell morphology around the injured area in CCI rats. A total of 6099 proteins were identified with FDR (false discovery rate) < 1%. 105 overlapping DEPs were identified (295 DEPs and 804 DEPs in CCI/Sham or XFZYD/CCI group respectively). Of these DEPs, 17 were regulated by XFZYD. Bioinformatics analysis showed the 17 DEPs were predominantly related to platelet activation and PI3K-Akt signaling pathway. PLG and CD34 were verified with molecular biotechnology.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Our study suggests that XFZYD may exert therapeutic effects through multi-pathways regulation in the treatment of TBI. This work may provide proteomics clues for the continuation researches on XFZYD in treating TBI.</p>

What problem does this paper attempt to address?

This paper aims to reveal the possible mechanisms of Xuefu Zhuyu decoction (XFZYD) in the treatment of acute Traumatic Brain Injury (TBI). Specifically, the study detected the protective effect of XFZYD on TBI through proteomics techniques and further explored its potential mechanism of action through bioinformatics analysis. ### Research Background - **Traumatic Brain Injury (TBI)**: It is a craniocerebral injury and brain dysfunction caused by external forces. It is one of the leading causes of death in young people and also a major cause of death and disability in all age groups. The pathophysiological process of TBI is complex and dynamic, including primary and secondary brain injuries. - **Xuefu Zhuyu Decoction (XFZYD)**: It is a traditional Chinese medicine formula composed of 11 herbs, which has the functions of promoting blood circulation and removing blood stasis. Previous studies have shown that XFZYD is effective in treating cardiovascular and cerebrovascular diseases (including TBI), but its underlying molecular mechanisms remain unclear. ### Research Objectives - **To reveal the possible mechanisms of XFZYD in the treatment of acute TBI**: Detect differentially expressed proteins (DEPs) in the cerebral cortex of TBI model rats through proteomics techniques, and analyze the functions and pathways of these proteins using bioinformatics methods to explore the multi - target and multi - pathway regulatory mechanisms of XFZYD. ### Methods - **Animal Model**: Use the controlled cortical impact (CCI) rat model and divide it into three groups: Sham - operated group (Sham), CCI group, and XFZYD group. - **Behavioral Assessment**: Evaluate neurological function through the modified Neurological Severity Score (mNSS). - **Brain Water Content Determination**: Evaluate brain edema. - **Histological Staining**: HE staining and Nissl staining are used to evaluate cell morphology. - **Proteomics Analysis**: Use tandem mass tag (TMT) quantitative proteomics techniques to detect protein changes in the cerebral cortex. - **Bioinformatics Analysis**: Include Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and protein - protein interaction (PPI) network analysis. ### Results - **Neuroprotective Effect**: XFZYD significantly improved the neurological function of CCI rats, reduced brain edema, and improved the cell morphology around the injured area. - **Proteomics Analysis**: A total of 6,099 quantifiable proteins were identified, among which 105 differentially expressed proteins (DEPs) overlapped in the CCI group and the XFZYD group. Among these 105 DEPs, 17 proteins were reversely regulated by XFZYD. - **Bioinformatics Analysis**: These 17 DEPs were mainly related to platelet activation and the PI3K - Akt signaling pathway. PLG and CD34 were verified by molecular biology techniques. ### Conclusions - **XFZYD plays a therapeutic role in the treatment of TBI through a multi - pathway regulatory mechanism**. This study provides a basis for further exploring the proteomics clues of XFZYD in the treatment of TBI.

TMT-based proteomics analysis reveals the protective effects of Xuefu Zhuyu decoction in a rat model of traumatic brain injury